We are joining forces with Canaccord Genuity
We are very excited to share that we have agreed to join forces with Canaccord Genuity – a leading full-service investment bank serving growth companies in the middle market. This is an important milestone in our journey and we wanted to update you on why we’ve taken this decision and what it means for you.
Since it was founded in 1988, Results has grown into a leading independent sector-focussed advisory firm, advising corporate, founder-owned and private equity clients on transactions in the healthcare and technology sectors. We’ve advised on over 60 transactions in our focus sectors in the last three years alone. The combination with Canaccord Genuity will enable us to enhance our global reach, expand our advisory capability and continue to deliver outstanding outcomes for our clients.
What We Do
We’ve been providing independent M&A and corporate finance advice and execution services to entrepreneurs, corporates and investors in the technology and healthcare sectors for over 30 years. Whether your aim is to realise value or to find a partner for future growth, we will be your partner
When the time comes, we’re by your side every step of the way. We help you evaluate your market, find the right buyer, and deliver the true value of your business
With a strong track record in company carve-outs, we can help you realign your portfolio and redeploy capital to the growth of your core business
We support clients with in-licensing and out-licensing of drugs, technologies and facilities. We understand the complexities that are unique to licensing deals
We understand that optimising terms is critical, but so is finding the right partner for growth. We help articulate your equity story, target the best investors and negotiate the right deal
Having completed over 300 transactions, we bring the breadth of perspectives and depth of business experience to provide advice on strategic options for businesses
Pharma Commercialisation Services Update – September 2022
Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]
Marketing Services: Global M&A and Public Company Performance – H1 2022
We are pleased to share with you the H1 2022 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. H1 2022 has been an exciting and active period for M&A in the marketing services vertical with 425 deals recorded globally. This represents a 15% and […]